000			01474 a2200445 4500
005			20250512001706.0
264		0	_c19870717
008			198707s 0 0 eng d
022			_a0037-1963
040			_aNLM _beng _cNLM
100	1		_aColeman, M
245	0	0	_aAdvances in chemotherapy for large cell lymphoma. _h[electronic resource]
260			_bSeminars in hematology _cApr 1987
300			_a8-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAge Factors
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBleomycin _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Tolerance
650	0	4	_aForecasting
650	0	4	_aHumans
650	0	4	_aLeucovorin _xtherapeutic use
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aProcarbazine _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aTime Factors
650	0	4	_aVincristine _xtherapeutic use
700	1		_aGerstein, G
700	1		_aTopilow, A
700	1		_aLebowicz, J
700	1		_aBerhardt, B
700	1		_aChiarieri, D
700	1		_aSilver, R T
700	1		_aPasmantier, M W
773	0		_tSeminars in hematology _gvol. 24 _gno. 2 Suppl 1 _gp. 8-20
999			_c2444836 _d2444836